Cytokine-triggered decreases in levels of phosphorylated eukaryotic initiation factor 4G in skeletal muscle during sepsis.
Chronic septic abscess formation causes an inhibition of protein synthesis in gastrocnemius that is not observed in rats with a sterile abscess. The inhibition is associated with an impaired translation initiation. The present study was designed to investigate the effects of sepsis on the level of phosphorylated eukaryotic initiation factor (eIF) 4G in gastrocnemius after induction of a chronic intra-abdominal sterile or septic abscess as a possible mechanism to account for the impairment of translation initiation during sepsis. The extent of phosphorylated eIF4G was reduced by more than 50% (P< 0.05) and 68% (P < 0.01) in gastrocnemius after 3 and 5 days, respectively, and returned to control values after 14 days of abscess formation in septic rats compared with sterile inflammatory animals. To examine the mediators of the septic process contributing to the decreased levels of phosphorylated eIF4G, the cytokine response to sepsis was pharmacologically modulated. First, treatment of septic rats with tumor necrosis factor (TNF) binding protein or interleukin (IL) 1 receptor antagonist increased the level of phosphorylated eIF4G. Second, infusion of TNF-alpha for 24 h in control rats resulted in a 70% decrease in phosphorylated eIF4G. Third, infusion of IL-1ra led to an increase in the level of phosphorylation of eIF4G in rats infused with TNF-alpha. Taken together, the data indicate that a cytokine-dependent decrease in the steady state phosphorylation of eIF4G is a possible mechanism accounting for the inhibition of skeletal muscle protein synthesis during sepsis. Furthermore, the findings support a role of IL-1 as the proinflammatory mediator responsible for the reduced level of phosphorylated eIF4G.
Vary
Thomas C
TC
Department of Cellular and Molecular Physiology, The Pennsylvania State University College of Medicine, 500 University Drive, Hershey, PA 17033, USA. tvary@psu.edu
Deiter
Gina
G
Lang
Charles H
CH
D000818:Animals; D016207:Cytokines / Q000378:metabolism*; D039603:Eukaryotic Initiation Factor-4G / Q000737:chemistry / Q000378:metabolism*; D053590:Interleukin 1 Receptor Antagonist Protein / Q000378:metabolism; D007375:Interleukin-1 / Q000378:metabolism / Q000502:physiology*; D008297:Male; D018482:Muscle, Skeletal / Q000378:metabolism*; D010766:Phosphorylation; D011506:Proteins / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D018805:Sepsis; D013997:Time Factors; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
D016207:Cytokines; D039603:Eukaryotic Initiation Factor-4G; D053590:Interleukin 1 Receptor Antagonist Protein; D007375:Interleukin-1; D011506:Proteins; D014409:Tumor Necrosis Factor-alpha